Zoetis Inc.
LSE: 0M3Q.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Kristin C. Peck
- Employees
- 13,800
- Headquarters
- Parsippany, United States
- IPO year
- 2018
- Market cap
- $39.4B
- Website
- https://www.zoetis.com
Loading 0M3Q…
Loading profile data…Frequently asked questions about 0M3Q
What does Zoetis Inc. (0M3Q.L) do?
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses....
Where does 0M3Q.L trade?
Zoetis Inc. (0M3Q.L) trades on the London Stock Exchange.
What sector is 0M3Q.L in?
Zoetis Inc. (0M3Q.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Zoetis Inc.?
Kristin C. Peck is the chief executive officer of Zoetis Inc. (0M3Q.L).
Where is Zoetis Inc. headquartered?
Zoetis Inc. is headquartered in United States.
Does 0M3Q.L pay a dividend?
Yes — Zoetis Inc. (0M3Q.L) paid a trailing twelve-month dividend of USD 2.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 0M3Q.L go public?
Zoetis Inc. (0M3Q.L) completed its initial public offering in 2018.